Skip to NavigationSkip to content

Pharmafile.com's weekly COVID-19 news round-up

Published on 16/09/20 at 10:56am

The coronavirus news this week focuses on AstraZeneca’s vaccine candidate, as global trials for itsmuch-hyped vaccine were halted after an unexplained illness was identified in one of the participants but Pascal Soriot, Chief Executive of AstraZeneca, said that the company’s vaccine could still be available this year.

In other news, England increased lockdown restrictions on Monday as coronavirus cases surged across the country.

1. Gatherings of over six people to be banned in England from MondayPublished on 09/09/20

England is set to increase lockdown restrictions across the country after a surge in coronavirus cases.

2. Chinese drug firm says thousands have been vaccinated for COVID-19 on an emergency use schemePublished on 08/09/20

Hundreds of thousands of people in China have been inoculated with two experimental vaccines on an emergency use scheme, according to a state-owned vaccine developer.

3. AstraZeneca Chief Executive says vaccine is still possible this yearPublished on 10/09/20

Pascal Soriot, Chief Executive of AstraZeneca, said that the company’s vaccine could still be available this year, despite the clinical trials being paused after a participant became ill.

4. AstraZeneca slams brakes on COVID-19 vaccine trial over unexplained participant illnessPublished on 09/09/20

Global trials for AstraZeneca’s much-hyped COVID-19 vaccine, currently in development in partnership with the University of Oxford, have been halted after an unexplained illness was identified in one of the participants.

5. Pfizer CEO says company’s COVID-19 vaccine will be available this year if FDA approves the candidate by OctoberPublished on 14/09/20

Albert Bourla, the CEO of Pfizer, has said that the company’s vaccine for COVID-19 could be used by the general public before the end of the year if the FDA approves it by the end of October.

Conor Kavanagh

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches